Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 11:02:24 14/10/2026 BST			5-day change	1st Jan Change
2,539.40 ^INR	+0.21%		-7.93%	+2.77%

08-03	GSK India first-quarter profit rises on steady vaccine demand	RE
08-03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	430,190	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	11.21%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	430,190	430,190
Change	-	-18.99%	58.51%	48.08%	-20.64%	11.21%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	36.9x	32.1x
PBR	10.6x	12.9x	18.5x	25x	17.1x	16.2x	13.6x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3x	2.1x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.1x	9.11x
EV / Revenue	0x	0x	0x	0x	0x	10.1x	9.11x
EV / EBITDA	0x	0x	0x	0x	0x	29x	25.2x
EV / EBIT	0x	0x	0x	0x	0x	29.3x	25.1x
EV / FCF	0x	0x	0x	0x	0x	35.8x	32.6x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.79%	3.06%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.16%	1.16%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,539.40	2,539.40
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	36.84x	-	-	1.16%	4.52B
ELI LILLY AND COMPANY	33.19x	12.03x	25.3x	0.59%	1,040B
JOHNSON & JOHNSON	36.75x	6.12x	17.02x	2.15%	599B
ABBVIE INC.	34.92x	8.07x	16.64x	2.53%	485B
MERCK & CO., INC.	109.67x	5.8x	24.85x	2.4%	350B
ROCHE HOLDING AG	19.42x	4.74x	11.78x	2.78%	345B
NOVARTIS AG	20.05x	5.27x	12.97x	3.02%	272B
ASTRAZENECA PLC	20.63x	4.17x	11.97x	2.12%	244B
AMGEN INC.	26.21x	6.79x	12.15x	2.44%	223B
GILEAD SCIENCES, INC.	-43.22x	6.62x	25.76x	2.23%	183B
Average	29.45x	6.62x	17.61x	2.14%	374.73B
Weighted average by Cap.	33.94x	7.73x	19.04x	1.93%